Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

See all formats and pricing



Select Volume and Issue


Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions

David W. Klaver1, 2 / Matthew C.J. Wilce2 / Hao Cui1, 3 / Amos C. Hung1 / Robert Gasperini1 / Lisa Foa1 / David H. Small1, 2

1Menzies Research Institute, University of Tasmania, Hobart, Tasmania 7000, Australia

2Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia

3Department of Pharmacy, University of Tasmania, Hobart, Tasmania 7000, Australia

Corresponding author

Citation Information: Biological Chemistry. Volume 391, Issue 8, Pages 849–859, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: 10.1515/bc.2010.089, May 2010

Publication History

Published Online:


Alzheimer's disease (AD) is characterized by the extracellular deposition of the β-amyloid protein (Aβ). Aβ is a fragment of a much larger precursor protein, the amyloid precursor protein (APP). Sequential proteolytic cleavage of APP by β-secretase and γ-secretase liberates Aβ from APP. The aspartyl protease BACE1 (β-site APP-cleaving enzyme 1) catalyses the rate-limiting step in the production of Aβ, and as such it is considered to be a major target for drug development in Alzheimer's disease. However, the development of a BACE1 inhibitor therapy is problematic for two reasons. First, BACE1 has been found to have important physiological roles. Therefore, inhibition of the enzyme could have toxic consequences. Second, the active site of BACE1 is relatively large, and many of the bulky compounds that are needed to inhibit BACE1 activity are unlikely to cross the blood-brain barrier. This review focuses on the structure BACE1, current therapeutic strategies based on developing active-site inhibitors, and new approaches to therapy involving targeting the expression or post-translational regulation of BACE1.

Keywords: Alzheimer's disease; amyloid; β-secretase; β-site APP cleaving enzyme (BACE); protease; therapy

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Nan Lin, Li-min Chen, Xiao-dong Pan, Yuan-gui Zhu, Jing Zhang, Yan-qing Shi, and Xiao-chun Chen
Molecular Neurobiology, 2015
Hezekiel M. Kumalo, Soumendranath Bhakat, and Mahmoud E. Soliman
Journal of Biomolecular Structure and Dynamics, 2015, Page 1
Haibin Liu, Lirong Wang, Mingliang Lv, Rongrong Pei, Peibo Li, Zhong Pei, Yonggang Wang, Weiwei Su, and Xiang-Qun Xie
Journal of Chemical Information and Modeling, 2014, Volume 54, Number 4, Page 1050
Edgar Dawkins and David H. Small
Journal of Neurochemistry, 2014, Volume 129, Number 5, Page 756
María Isabel Fernández-Bachiller, André Horatscheck, Michael Lisurek, and Jörg Rademann
ChemMedChem, 2013, Volume 8, Number 7, Page 1041
James E Galvin
Neurodegenerative Disease Management, 2012, Volume 2, Number 3, Page 291
Puneet Kacker, Matteo Masetti, Martina Mangold, Giovanni Bottegoni, and Andrea Cavalli
Journal of Chemical Information and Modeling, 2012, Volume 52, Number 5, Page 1079
David H. Small and Marie-Isabel Aguilar
Journal of Neurochemistry, 2012, Volume 121, Number 5, Page 695
Johannes Prox, Andrea Rittger, and Paul Saftig
Experimental Brain Research, 2012, Volume 217, Number 3-4, Page 331
Manel Ben Aissa, Marie-Claude April, Lucien-Junior Bergeron, Jean-Pierre Perreault, and Georges Levesque
International Journal of Alzheimer's Disease, 2012, Volume 2012, Page 1
Philip Seeman and Neil Seeman
Synapse, 2011, Volume 65, Number 12, Page 1289
Alison E Mungenast and Li-Huei Tsai
Future Neurology, 2011, Volume 6, Number 4, Page 481
Shih-Jei Tsai, C. Perry Chiu, Hui-Ting Yang, and Mei-Chin Yin
Journal of Agricultural and Food Chemistry, 2011, Volume 59, Number 11, Page 6319

Comments (0)

Please log in or register to comment.